Last reviewed · How we verify
BAY86-5300_YAZ-Flex
At a glance
| Generic name | BAY86-5300_YAZ-Flex |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAY86-5300_YAZ-Flex CI brief — competitive landscape report
- BAY86-5300_YAZ-Flex updates RSS · CI watch RSS
- Bayer portfolio CI